Vincerx Pharma, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
VINC on Nasdaq
Location
260 Sheridan Avenue, Suite 400, Palo Alto, California

Insiders trading volume in the past year

Vincerx Pharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ahmed M. Hamdy Chief Executive Officer, Director $1.71 M +$21.2 K +1.25% May 23, 2024
Raquel E. Izumi President and Chief Operations Officer, Director $1.62 M +$14.9 K +0.93% May 23, 2024
Tom C. Thomas General Counsel and Chief Legal Officer $218 K +$4.75 K +2.22% May 23, 2024
Christopher P. Lowe Director $38 K Aug 24, 2022
Alexander A. Seelenberger Chief Financial Officer $28.7 K +$9.97 K +53.1% May 23, 2024
Ruth E. Stevens Director May 23, 2024
Sooin Hwang Chief Business Officer Feb 14, 2022
John H. Lee Director May 23, 2024
Xiaoming Zhang Chief Technology Officer Feb 14, 2022
Hermes de Jesus Garban Chief Medical Officer Feb 14, 2022
Francisco D. Salva Director May 23, 2024
Rubric Capital Management LP 10%+ Owner Jan 20, 2022
Andrew I. McDonald Director, 10%+ Owner May 26, 2022
Brian Druker Director May 23, 2024
Laura I. Bushnell Director May 23, 2024

Recent Insider Transactions by Companies or Individuals for Vincerx Pharma, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership